IPR of pre-AIA patents isn’t unconstitutional, finds Fed Circuit

31-07-2019

Sarah Morgan

IPR of pre-AIA patents isn’t unconstitutional, finds Fed Circuit

zimmytws / Shutterstock.com

In a defeat for biotech company Celgene, the US Court of Appeals for the Federal Circuit has concluded that the retroactive application of inter partes review (IPR) proceedings to a pre-American Invents Act (AIA) patent isn’t unconstitutional.


Celgene, US Court of Appeals for the Federal Circuit, constitution, Coalition for Affordable Drugs, Kyle Bass, teratogenic, IPR, inter partes reviews

LSIPR